NAVB

Navidea Biopharmaceuticals Inc.

Delisted

NAVB was delisted on the 5th of October, 2023.

87 hedge funds and large institutions have $92.8M invested in Navidea Biopharmaceuticals Inc. in 2014 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 20 increasing their positions, 22 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

more funds holding in top 10

Funds holding in top 10:

9% less repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 22

99% less call options, than puts

Call options by funds: $81K | Put options by funds: $12.2M

Holders
87
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$81K
Puts
$12.2M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
51
$53K
52
$52K
53
$51K
54
$45K
55
$41K
56
$34K
57
$32K
58
$32K
59
$32K
60
$31K
61
$24K
62
$24K
63
$23K
64
$22.7K
65
$22K
66
$22K
67
$22K
68
$22K
69
$21K
70
$20K
71
$19K
72
$19K
73
$19K
74
$13K
75
$10K